Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
The biggest black hole breakthroughs of 2025 - 2American tourists left stranded in the Caribbean following flight cancellations after airspace closed for Maduro operation
- 3Find the Native Culinary Customs: Local Flavors
- 4Gaza humanitarian efforts reach key milestone as UNICEF vaccinates some 13,000 children
- 5EU Council president: Ukraine should receive binding guarantees
- How to avoid or deal with an outrageous medical bill
- EU Commission prepares €90bn Ukraine loan despite Hungary's veto
- Taylor Frankie Paul's domestic violence case is fueling discussions about DARVO. Experts say terms like this shouldn't be used lightly.
- The Reduced Portage Horse: An Inheritance Reconsidered for Present day Experience
- Report: Thailand strikes deal with Iran for safe passage of Hormuz
- Fundamental Home Items Each Animal person Needs
- Vaccine makers raise concerns over US panel's shift away from hepatitis B shots for newborns
- Scientist turns people’s mental images into text using ‘mind-captioning’ technology
- State asks High Court to reject challenge to anti-UNRWA laws ahead of Monday hearing
